BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16885837)

  • 1. [Methotrexate in psoriasis: are routine biopsies necessary?].
    Guillaume JC
    Ann Dermatol Venereol; 2006; 133(6-7):513-7. PubMed ID: 16885837
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate hepatotoxicity and the role of routine liver biopsy: a collective opinion.
    Sinclair RD; Rotstein H; Clemmens L; Prentice D; Rode J; Breen K
    Australas J Dermatol; 1995 Nov; 36(4):228-9. PubMed ID: 8593119
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
    Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP
    Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in psoriasis: consensus conference.
    Roenigk HH; Auerbach R; Maibach H; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B; Saraswat A; Kaur I
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
    Boffa MJ; Chalmers RJ; Haboubi NY; Shomaf M; Mitchell DM
    Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
    Berends MA; van Oijen MG; Snoek J; van de Kerkhof PC; Drenth JP; Han van Krieken J; de Jong EM
    Arch Dermatol; 2007 Dec; 143(12):1515-9. PubMed ID: 18087000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methotrexate in psoriasis: do we need to give a test dose?].
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012; 103(1):1-4. PubMed ID: 22093543
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver biopsies and methotrexate: a time for reconsideration?
    Zachariae H
    J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
    [No Abstract]   [Full Text] [Related]  

  • 11. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
    Zachariae H
    Dermatology; 2005; 211(4):307-8. PubMed ID: 16286736
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum liver tests in patients treated with methotrexate. A retrospective analysis].
    Correa G H; Paredes S N
    Rev Med Chil; 2007 Aug; 135(8):1002-8. PubMed ID: 17989857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose methotrexate induced asymptomatic keratinocyte dystrophy in a patient of psoriasis vulgaris.
    Behera B; Kumari R; Gochhait D; Thappa DM
    J Cutan Pathol; 2016 Dec; 43(12):1238-1241. PubMed ID: 27714834
    [No Abstract]   [Full Text] [Related]  

  • 15. Daily practice assessment of liver injury in patients with psoriasis on methotrexate.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2010 Jan; 162(1):211-3. PubMed ID: 19903179
    [No Abstract]   [Full Text] [Related]  

  • 16. Bullous drug eruption in a patient with psoriasis after a test dose of methotrexate.
    Sako EY; Famenini S; Wu JJ
    J Am Acad Dermatol; 2013 Nov; 69(5):e264-e265. PubMed ID: 24124857
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate in psoriasis: revised guidelines.
    Roenigk HH; Auerbach R; Maibach HI; Weinstein GD
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):145-56. PubMed ID: 3042816
    [No Abstract]   [Full Text] [Related]  

  • 18. Reconsidering liver biopsies during methotrexate therapy.
    Henning JS; Gruson LM; Strober BE
    J Am Acad Dermatol; 2007 May; 56(5):893-4. PubMed ID: 17437899
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 20. Noninvasive monitoring for methotrexate hepatotoxicity.
    MacDonald A; Burden AD
    Br J Dermatol; 2005 Mar; 152(3):405-8. PubMed ID: 15787807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.